Nucleon HT Genomic DNA Extraction Kit from GE Healthcare, formerly Amersham Biosciences
...fficient purification of DNA and oligonucleotides ...w.Prepacked with Sephadex G-25 DNA Grade in distil...vailable in three sizes depending on sample volume...).Useful for small-scale purification, desalting a...
Goat Anti-Human ROR1 Polyclonal Antibody, Unconjugated from R&D Systems
Mouse Anti-Human Rad1 Monoclonal Antibody, Unconjugated, Clone 33 from R&D Systems
Biology Products:(Date:11/19/2009)...NA, Austria, November 19 AFFiRiS A...e product candidate at an unexpectedly early,stage...nned to enter into,Phase II clinical trial early i...ollows the completion of two Phase I trials with t... fast decision on the first interim,analysis of th...
(Date:11/18/2009)...onal Institute of Standards and Technology (NIST) ...method for detecting and measuring elusive hazards...e spoilage in food or pesticides distributed in so...sensitive than conventional techniques for detecti...water molecules, having distinct electrically posi...
(Date:11/18/2009)...agine a polka-dotted postage stamp that can sniff ...nging colors. , As reported in the Sept. 13 issu...ck and his team at the University of Illinois have...ction of toxic industrial chemicals (TICs) that is...izing odors. This sensor array could be useful in...
(Date:11/18/2009)...alif., Nov. 18 Sangamo B...that data from the University of Pennsylvania inve...,s zinc finger nuclease (ZFN) based product, SB-72...ly disclosed on the internet. ,, Data were pres...nsylvania School of Medicine from a single subject...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Prototype NIST method detects and measures elusive hazards 2Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2